What is Castor?
Castor operates as a sophisticated cloud-based clinical data management platform designed to optimize the capture and integration of research data. By bridging the gap between clinical environments and patient-reported outcomes, the platform empowers researchers to accelerate trial timelines while maintaining high standards of data integrity. In an industry characterized by stringent regulatory requirements and the need for interoperability, Castor provides a scalable architecture that supports diverse research methodologies, positioning itself as an essential tool for modern medical innovation and life sciences research.
How much funding has Castor raised?
Castor has raised a total of $1.8M across 1 funding round:
Other Financing Round
$1.8M
Other Financing Round (2021): $1.8M with participation from Vast Ventures, Canary, First Check Ventures, Daniel Vogel, and Latitude Financial Services
Key Investors in Castor
Vast Ventures
Vast Ventures is a manifesto-driven venture fund that invests in disruptive companies aimed at creating a global impact, with a specific focus on improving worldwide health and human potential.
First Check Ventures
First Check Ventures is an investment firm founded in 2020 that focuses on early-stage startups globally, partnering with visionary entrepreneurs across sectors including healthcare and fintech.
Canary
Canary is an established firm with a long history in industrial services, providing strategic capital to support growth-oriented enterprises.
What's next for Castor?
With this major enterprise-level funding, Castor is well-positioned to accelerate its product roadmap and expand its footprint in the global clinical research market. The company is expected to prioritize the enhancement of its data analytics capabilities and the integration of advanced machine learning models to further automate trial processes. As the demand for decentralized clinical trials continues to rise, Castor's strategic focus will likely center on strengthening its cloud infrastructure to support larger, multi-center studies. This capital deployment will be instrumental in maintaining the company's competitive edge, fostering long-term growth, and driving further adoption of its platform among pharmaceutical companies and academic research institutions worldwide.
See full Castor company page
